These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22950559)

  • 1. Hemangiomas: new insight and medical treatment.
    Neri I; Balestri R; Patrizi A
    Dermatol Ther; 2012; 25(4):322-34. PubMed ID: 22950559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What's new about infantile hemangiomas?].
    Dreyfus I; Maza A; Mazereeuw-Hautier J
    Arch Pediatr; 2013 Jul; 20(7):809-16. PubMed ID: 23628116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of infantile hemangiomas.
    Püttgen KB
    Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
    Cavalli R; Novotna V; Buffon RB; Gelmetti C
    G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.
    Vivas-Colmenares GV; Bernabeu-Wittel J; Alonso-Arroyo V; Matute de Cardenas JA; Fernandez-Pineda I
    Pediatr Dermatol; 2015; 32(3):348-52. PubMed ID: 25721095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for the treatment of subglottic hemangiomas.
    Raol N; Metry D; Edmonds J; Chandy B; Sulek M; Larrier D
    Int J Pediatr Otorhinolaryngol; 2011 Dec; 75(12):1510-4. PubMed ID: 21944056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
    Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemangioma. New aspects of pathogenesis, differential diagnosis and therapy].
    Höger PH
    Hautarzt; 2012 Feb; 63(2):112-20. PubMed ID: 22349036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile hemangiomas of the head and neck.
    Huoh KC; Rosbe KW
    Pediatr Clin North Am; 2013 Aug; 60(4):937-49. PubMed ID: 23905829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
    Mazereeuw-Hautier J; Hoeger PH; Benlahrech S; Ammour A; Broue P; Vial J; Ohanessian G; Léauté-Labrèze C; Labenne M; Vabres P; Rössler J; Bodemer C
    J Pediatr; 2010 Aug; 157(2):340-2. PubMed ID: 20488455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
    Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
    J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.